Schrank S, Honekamp W, Bewertung des Patientenmanagements aus Patientensicht, Ergebnisse einer explorativen Zufriedenheitsstudie in der Metropolregion Rhein-Neckar, Heilberufe SCIENCE, Springer-Verlag, Dezember 2011, DOI 10.1007/s16024-011-0045-4

Laterza RM, De Gennaro M, Tubaro A, Koelbl H. Female pelvic congenital malformations Part II: sexuality, reproductive outcomes and psychological impact. Eur J Obstet Gynecol Reprod Biol. 2011 Jul

Laterza RM, De Gennaro M, Tubaro A, Koelbl H. Female pelvic congenital malformations. Part I: embryology, anatomy and surgical treatment. Eur J Obstet Gynecol Reprod Biol. 2011 Jul 21.

Skala C, Renezeder K, Albrich S, Puhl A, Laterza RM, Naumann G, Koelbl H. The IUGA/ICS classification of complications of prosthesis and graft insertion : A comparative experience in incontinence and prolapse surgery. Int Urogynecol J. 2011 Jul 26.

Skala CE, Renezeder K, Albrich S, Puhl A, Laterza RM, Naumann G, Koelbl H. Mesh-complications following prolapse surgery: management and outcome. Eur J Obstet Gynecol Reprod Biol. 2011 Aug 6.

Tubaro A, Koelbl H, Laterza R, Khullar V, de Nunzio C. Ultrasound imaging of the pelvic floor: where are we going? Neurourol Urodyn. 2011 Jun;30(5):729-34.

Albrich S, Laterza R, Skala C, Salvatore S, Koelbl H, Naumann G. Impact of mode of delivery on levator morphology: a prospective observational study with three-dimensional ultrasound early in the postpartum period. BJOG. 2011 Oct 10. Doi: 10.1111/j. 1471-0528.2011.03152.


Puhl AG, Zelazny J, Galetzka D, Skala C, Frey-Mahn G, Wellek B, Koelbl H. Unbalanced translocation 6p/16q (partial monosomy 6p and trisomy 16q): prenatal diagnosis and cytogenetics. Eur J Obstet Gynecol Reprod Biol. 2010 Jun;150(2) 

Cartwright R, Tikkinen KA, Vierhout ME, Koelbl H. How to write an ICS/IUGA conference abstract. Int Urogynecol J Pelvic Floor Dysfunct. 2010 May;21(5):509-13.

Tchirikov M, Steetskamp J, Hohmann M, Koelbl H. Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans. Eur J Obstet Gynecol Reprod Biol. 2010 May 18.

Smith AR, Koelbl H. Is mid-urethral placement of synthetic minimal access tapes important in stress urinary incontinence surgery? Neurourol Urodyn. 2010 Apr;29(4):676-8.

Brase JC, Schmidt M, Fischbach T, Sültmann H, Bojar H, Koelbl H, Hellwig B, Rahnenführer J, Hengstler JG, Gehrmann MC. ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction. Clin Cancer Res. 2010 Apr 15;16(8):2391-401. 

Schmidt M, Petry IB, Böhm D, Lebrecht A, von Törne C, Gebhard S, Gerhold-Ay A, Cotarelo C, Battista M, Schormann W, Freis E, Selinski S, Ickstadt K, Rahnenführer J, Sebastian M, Schuler M, Koelbl H, Gehrmann M, Hengstler JG. Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer. Breast Cancer Res Treat. 2010 Mar 30. 

Siggelkow W, Schmidt M, Skala C, Boehm D, von Forstner S, Koelbl H, Tresch A. A new algorithm for improving fetal weight estimation from ultrasound data at term. Arch Gynecol Obstet. 2010 Feb 20. 

Petry IB, Fieber E, Schmidt M, Gehrmann M, Gebhard S, Hermes M, Schormann W, Selinski S, Freis E, Schwender H, Brulport M, Ickstadt K, Rahnenführer J, Maccoux L, West J, Kölbl H, Schuler M, Hengstler JG. ERBB2 induces an antiapoptotic expression pattern of Bcl-2 family members in node-negative breast cancer. Clin Cancer Res. 2010 Jan 15;16(2):451-60.

Abrams P, Andersson KE, Birder L, Brubaker L, Cardozo L, Chapple C, Cottenden A, Davila W, de Ridder D, Dmochowski R, Drake M, Dubeau C, Fry C, Hanno P, Smith JH, Herschorn S, Hosker G, Kelleher C, Koelbl H, Khoury S, Madoff R, Milsom I, Moore K, Newman D, Nitti V, Norton C, Nygaard I, Payne C, Smith A, Staskin D, Tekgul S, Thuroff J, Tubaro A, Vodusek D, Wein A, Wyndaele JJ; Members of Committees. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn.

de Boer TA, Salvatore S, Cardozo L, Chapple C, Kelleher C, van Kerrebroeck P, Kirby MG, Koelbl H, Espuna-Pons M, Milsom I, Tubaro A, Wagg A, Vierhout ME.
Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2010;29(1):30-9.

Blohmer JU, Schmid P, Hilfrich J, Friese K, Kleine-Tebbe A, Koelbl H, Sommer H, Morack G, Wischnewsky MB, Lichtenegger W, Kuemmel S. Epirubicin and cyclophosphamide versus epirubicin and docetaxel as first-line therapy for women with metastatic breast cancer: final results of a randomised phase III trial. Ann Oncol. 2010 Jan 20.


Seliger G, Mueller LP, Kegel T, Kantelhardt EJ, Grothey A, Groe R, Strauss HG, Koelbl H, Thomssen C, Schmoll HJ. Phase 2 trial of docetaxel, gemcitabine, and oxaliplatin combination chemotherapy in platinum- and paclitaxel-pretreated epithelial ovarian cancer. Int J Gynecol Cancer. 2009 Nov;19(8):1446-53.

Tchirikov M, Gatopoulos G, Strohner M, Puhl A, Steetskamp J. Two new
approaches in intrauterine tracheal occlusion using an ultrathin fetoscope.
Laryngoscope. 2009 Nov 30.

Schroth W, Goetz MP, Hamann U, Fasching PA, Schmidt M, Winter S, Fritz P, Simon W, Suman VJ, Ames MM, Safgren SL, Kuffel MJ, Ulmer HU, Boländer J, Strick R, Beckmann MW, Koelbl H, Weinshilboum RM, Ingle JN, Eichelbaum M, Schwab M, Brauch H. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. JAMA. 2009 Oct 7;302(13):1429-36.

Passuello V, Puhl AG, Wirth S, Steiner E, Skala C, Koelbl H, Kohlschmidt N.
Pregnancy Outcome in Maternal Crigler-Najjar Syndrome Type II: A Case Report and Systematic Review of the Literature. Fetal Diagn Ther. 2009 Sep 11.

Schmidt M, Scheulen ME, Dittrich C, Obrist P, Marschner N, Dirix L, Schmidt M, Rüttinger D, Schuler M, Reinhardt C, Awada A. An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy inpatients with metastatic breast cancer. Ann Oncol. 2009 Jul 24

Sebastian M, Kuemmel A, Schmidt M, Schmittel A. Catumaxomab: A bispecific
trifunctional antibody. Drugs Today (Barc). 2009 Aug;45(8):589-97.

Tchirikov M. Successful Tracheal Occlusion Using Ultrathin Fetoscopic
Equipment Combined with Real-Time Three-Dimensional Ultrasound. Eur Surg Res. 2009 Jun 10;43(2):204-207.

Boehm DU, Lebrecht A, Eckhardt T, Albrich S, Schmidt M, Siggelkow W,
Kandelhardt E, Koelbl H.
Quality of life and adjuvant tamoxifen treatment in
breast cancer patients. Eur J Cancer Care (Engl). 2009 May 21.

Lebrecht A, Boehm D, Schmidt M, Koelbl H, Grus FH. Surface-enhanced Laser
Desorption/Ionisation Time-of-flight Mass Spectrometry to Detect Breast Cancer
Markers in Tears and Serum. Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):75-83.

Lebrecht A, Boehm D, Schmidt M, Koelbl H, Schwirz RL, Grus FH. Diagnosis of
breast cancer by tear proteomic pattern. Cancer Genomics Proteomics. 2009

Schmidt M, Hengstler JG, von Törne C, Koelbl H, Gehrmann MC. Coordinates in the universe of node-negative breast cancer revisited. Cancer Res. 2009 Apr 1;69(7):2695-8.

Skala CE, Petry IB, Gebhard S, Hengstler JG, Albrich SB, Maltaris T, NaumannG, Koelbl H. Isolation of fibroblasts for coating of meshes for reconstructive surgery: differences between mesh types. Regen Med. 2009 Mar;4(2):197-204. 

Grimm C, Kantelhardt E, Heinze G, Polterauer S, Zeillinger R, Kölbl H, Reinthaller A, Hefler L. The prognostic value of four interleukin-1 gene polymorphisms in Caucasian women with breast cancer: a multicenter study. BMC Cancer. 2009 Mar 6;9:78.

Kalkum G, Macchiella D, Reinke J, Kölbl H, Beck M. Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease. Eur J Obstet Gynecol Reprod Biol. 2009 Feb 20. 

Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsässer A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol. 2009 Feb;20(2):258-64. Epub 2008 Sep 29.

Tchirikov M, Strohner M, Förster D, Hüneke B.  A combination of umbilical artery PI and normalized blood flow volume in the umbilical vein: Venous-arterial index for the prediction of fetal outcome.
Eur J Obstet Gynecol Reprod Biol. 2009 Jan 9. [Epub ahead of print]


Tchirikov M, Strohner M, Popovic S, Hecher K, Schröder HJ.
Cardiac output following fetoscopic coagulation of major placental vessels in
fetal sheep. Ultrasound Obstet Gynecol. 2008 Dec;32(7):917-22.

Schmidt M, Victor A, Bratzel D, Boehm D, Cotarelo C, Lebrecht A, Siggelkow W, Hengstler JG, Elsäßer A, Gehrmann M, Lehr HA, Koelbl H, von Minckwitz G, Harbeck N, Thomssen C. Long-term outcome prediction by clinicopathological risk classification algorithms in node-negative breast cancer--comparison between Adjuvant!, St Gallen, and a novel risk algorithm used in the prospective randomized Node-Negative-Breast Cancer-3 (NNBC-3) trial. Ann Oncol. 2008 Sep 29.

Schmidt M, Hasenclever D, Schaeffer M, Boehm D, Cotarelo C, Steiner E,
Lebrecht A, Siggelkow W, Weikel W, Schiffer-Petry I, Gebhard S, Pilch H, Gehrmann M, Lehr HA, Koelbl H, Hengstler JG, Schuler M.
 Prognostic effect of epithelial cell adhesion molecule overexpression in untreated node-negative breast cancer. Clin Cancer Res. 2008 Sep 15;14(18):5849-55.

Schmidt M, Böhm D, von Törne C, Steiner E, Puhl A, Pilch H, Lehr HA, Hengstler JG, Kölbl H, Gehrmann M. The humoral immune system has a key prognostic impact in node-negative breast cancer. Cancer Res. 2008 Jul 1;68(13):5405-13.

Boehm DU, Lebrecht A, Maltaris T, Schmidt M, Siggelkow W, Fischer S,
Kandelhart E, Koelbl H.
 Influence of resection volume on locoregional recurrence of breast cancer after breast-conserving surgery. Anticancer Res. 2008 Mar-Apr;28(2B):1207-11.

Maltaris T, Weigel M, Mueller A, Schmidt M, Seufert R, Fischl F, Koelbl H,
Dittrich R.
 Cancer and fertility preservation: fertility preservation in breast cancer patients. Breast Cancer Res. 2008;10(2):206. Epub 2008 Apr 29. Review.

Puhl AG, Steiner E, Krämer WW, Weltzien A, Skala C, Passuello V, Koelbl H.
Fetal urogenital sinus with consecutive hydrometrocolpos because of labial
fusion: prenatal diagnostic difficulties and postpartal therapeutic management.
Fetal Diagn Ther. 2008;23(4):287-92. Epub 2008 Apr 14.

Siggelkow W, Boehm D, Skala C, Grosslercher M, Schmidt M, Koelbl H.
The influence of macrosomia on the duration of labor, the mode of delivery and
intrapartum complications. Arch Gynecol Obstet. 2008 Dec;278(6):547-53. Epub 2008 Apr 1.

Steiner E, Pollow K, Hasenclever D, Schormann W, Hermes M, Schmidt M, Puhl A,
Brulport M, Bauer A, Petry IB, Koelbl H, Hengstler JG.
Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer. Gynecol Oncol. 2008 Mar;108(3):569-76. Epub 2008 Jan 28.

Gehrmann M., Schmidt M., Brase J.C., Roos P., Hengstler J.G. Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence? Pharmacogenomics 9:969-74, 2008 (IF: 3,371)

Hermes M., Schormann W., Brulport M., Uhlemann K., Lupatsch F., Horn L.C., Schumann A., Allgaier C., Weishaupt M, Engeland K., Müller G.A., Mössner J., Bauer A., Schiffer I.B., Gebhard S., Schmidt M., Lausch E., Prawitt D., Wilhelm C., Hengstler J.G. Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model. Br J Cancer. 2008 May 6;98(9):1525-32. Epub 2008 Apr 29 (IF: 3.449)


Haensel A, Naumann G, Höhle P, Rommens PM, Koelbl H.
 Osteomyelitis following a transobturator sling (TVT-O).
BJOG. 2007 Dec;114(12):1577-9. No abstract available.

Steiner E, Plata K, Interthal C, Schmidt M, Faldum A, Hengstler JG, Sakuragi
N, Watari H, Yamamoto R, Kölbl H.
 Diabetes mellitus is a multivariate independent prognostic factor in endometrial
carcinoma: a clinicopathologic study on 313 patients.
Eur J Gynaecol Oncol. 2007;28(2):95-7.

Boehm DU, Lebrecht A, Schmidt M, Siggelkow W, Lindner C, Litz A, Ulbrich E,
Koelbl H.
 Prognostic impact of haemoglobin levels in breast cancer.
Anticancer Res. 2007 Mar-Apr;27(2):1223-6.

Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer
IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch
H, Hengstler JG.
 Role of the progesterone receptor for paclitaxel resistance in primary breast
Br J Cancer. 2007 Jan 29;96(2):241-7. Epub 2007 Jan 9.

Steiner E., Pollow K., Hasenclever D., Schormann W., Hermes M., Schmidt M., Puhl A., Brulport M., Bauer A., Koelbl H. Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer Clin Cancer Res 2007: 0 (IF: 6.250 )

Vudattu N.K., Magalhaes I., Schmidt M., Seyfert-Margolis V., Maeurer M.J. Reduced numbers of Il-7 receptor (CD127) expressing immune cells and IL-7-signaling defects in peripheral blood from patients with breast cancer. Int J Cancer 121:1512-1519, 2007 (IF: 4.693)


Maltaris T, Koelbl H, Fischl F, Seufert R, Schmidt M, Kohl J, Beckmann MW,
Binder H, Hoffmann I, Mueller A, Dittrich R.
Xenotransplantation of human ovarian tissue pieces in gonadotropin-stimulated
SCID mice: the effect of ovariectomy.
Anticancer Res. 2006 Nov-Dec;26(6B):4171-6.

Steiner E, Schmidt M, Weikel W, Koelbl H.
Influence of diabetes mellitus and nodal distribution in endometrial cancer and
correlation to clinico-pathological prognostic factors.
Eur J Gynaecol Oncol. 2006;27(5):477-80.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Koelbl H.
Reconstructive plastic surgery in the treatment of vulvar carcinomas.
Eur J Obstet Gynecol Reprod Biol. 2008 Jan;136(1):102-9. Epub 2006 Nov 22.

Maltaris T, Boehm D, Dittrich R, Seufert R, Koelbl H.
Reproduction beyond cancer: a message of hope for young women.
Gynecol Oncol. 2006 Dec;103(3):1109-21. Epub 2006 Sep 25. Review.

Maltaris T, Seufert R, Fischl F, Schaffrath M, Pollow K, Koelbl H, Dittrich
 The effect of cancer treatment on female fertility and strategies for preserving
Eur J Obstet Gynecol Reprod Biol. 2007 Feb;130(2):148-55. Epub 2006 Sep 15.

Jünemann KP, Palmtag H, Hampel C, Heidler H, Naumann G, Kölbl H, van der
Horst C, Schultz-Lampel D.
 [Urinary incontinence and urodynamics.]
Urologe A. 2006 Sep;45(Supplement 04):106-121. German.

Naumann G, Kolbl H.
[Operative treatment of genital prolapse of the female: pros and cons of mesh
Gynakol Geburtshilfliche Rundsch. 2006;46(3):96-104. Review. German.

Hansen T, Wulgaris S, Siggelkow W, Kölbl H, Kirkpatrick CJ.
 [Massive adenomyosis in a patient with uterus septus completus]
Zentralbl Gynakol. 2006 Jun;128(3):153-6. German.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Kölbl H.
[Plastic reconstructive procedures of vulvar carcinoma: results and
Zentralbl Gynakol. 2006 Jun;128(3):143-8. German.

Weikel W, Schmidt M, Steiner E, Knapstein PG, Koelbl H.
Surgical therapy of recurrent vulvar cancer.
Am J Obstet Gynecol. 2006 Nov;195(5):1293-302. Epub 2006 May 8.

Hausherr C.K., Schiffer I.B., Gebhard S., Banic A., Tanner B., Koelbl H., Thoenes E., Beckers T. Spangenberg C., Prawitt D., Trost T., Zabel B., Oesch F., Hermes M. and Hengstler J.G. Dephosphorylation of p-ERK1/2 in relation to tumor remission after HER-2 and Raf1 blocking therapy in a conditional mouse tumor model. Molecular Carcinogenesis, 2006 May; 45(5):302-8. (IF: 3.194)

Tanner B., Hasenclever D., Stern K., Hermes M., Brulport M., Bauer A., Schormann W., Schiffer I.B., Gebhard S., Ullrich A. and Hengstler J.G. ErbB-3 (HER3) predicts survival in ovarian cancer. Journal of Clinical Oncology, 2006 September 10; 24(26):4317-23. (IF: 13.598)

Spangenberg C. , Lausch E.U. , Trost T.M. , Prawitt D., May A., Keppler R., Fees S.A., Reutzel D., Bell C., Schmitt S., Schiffer I.B., Weber A., Brenner W., Hermes M., Sahin U., Tureci O., Koelbl H., Hengstler J.G., Zabel B.U. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions. Cancer Research 2006 April 1;66(7):3715-25. (IF: 8.206)

Hengstler J.G., Bockamp E.O., Hermes M., Brulport M., Bauer A., Schormann W., Schiffer I.B., Hausherr C., Eshkind L., Antunes C., Franzen A., Krishnamurthi K., Lausch E., Lessig R., Chakrabarti T., Prawitt D., Zabel B. Spangenberg C. Oncogene-blocking therapies: new insights from conditional mouse tumor models. Curr Cancer Drug Targets. 2006 Nov;6(7):603-12. Review. (IF: 5.385)

Teifke A., Behr O. Schmidt M., Victor A., Vomweg T.W., Thelen M., Lehr, H.A. Dynamic MR Imaging of benign and malignant breast lesions: correlation with microvessel distribution pattern and histological characteristics of prognosis. Radiology, 239: 351-360, 2006 (IF: 5.251)


Naumann G, Koelbl H.
Pharmacotherapy of female urinary incontinence.
J Br Menopause Soc. 2005 Dec;11(4):160-5. Review.

Siggelkow W, Lebrecht A, Kölbl H, Faridi A.
Dual-plane implant positioning for capsular contracture of the breast in
combination with mastopexy.
Arch Gynecol Obstet. 2005 Dec;273(2):79-85. Epub 2005 Jul 14.

Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H,
Weikel W, Kölbl H, Lehr HA.
Long-term prognostic significance of HER-2/neu in untreated node-negative breast
cancer depends on the method of testing.
Breast Cancer Res. 2005;7(2):R256-66. Epub 2005 Jan 26.

Boehm DU, Munz W, Seufert R, Pollow K.
Severe virilization in a postmenopausal woman: a case report.
Zentralbl Gynakol. 2005 Apr;127(2):99-101. German.

Trost T.M., Lausch E.U., Fees S.A., Schmitt S., Enklaar T., Reutzel D., Brixel L.R., Schmidtke P., Maringer M., Schiffer I.B., Heimerdinger C.K., Hengstler J.G., Fritz G., Bockamp E.O., Prawitt D., Zabel B.U., Spangenberg C. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
Cancer Research 2005 Feb 1; 65 (3):840-9. (IF: 8.206)

I.B. Schiffer, C.K. Hausherr, E. Fieber, S. Gebhard, F. Oesch, J.G. Hengstler and H. Koelbl. Konditionale Expression des Onkogenes HER-2/neu  in einem Maustumor – Modell. Geburtshilfe und Frauenheilkunde, September 2005 (66), S40-41. (IF: 0.502)

Mohrmann G., Hengstler J.G., Hofmann T.G., Endele S.U., Lee B., Stelzer C., Zabel B., Brieger J., Hasenclever D., Tanner B., Sagemueller J., Sehouli J., Will H., Winterpacht A. SPOC1, a novel PHD-finger protein: association with residual disease and survival in ovarian cancer. Int J Cancer. 2005 Sep 10;116(4):547-54. (IF: 3.403)


Lebrecht A, Grimm C, Euller G, Ludwig E, Ulbrich E, Lantzsch T, Hefler L,
Koelbl H.
Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast.
Int J Biol Markers. 2004 Jul-Sep;19(3):236-9.

Schmidt M., Bremer E., Victor A., Lehr H.A., Kölbl H. Predictive factors for the in vitro drug sensitivity to paclitaxel and epirubicin in primary breast cancer Breast Cancer Res Treat 2004; 88: 51f (Suppl1) (IF: 2.879)

Tanner B., Grimme S, Schiffer I., Heimerdinger C., Schmidt M., Dutkowski P., Neubert S., Oesch F., Franzen A., Kolbl H., Fritz G., Kaina B., Hengstler JG. Nuclear expression of apurinic/apyrimidinic endonuclease increases with progression of ovarian carcinomas. Gynecol Oncol 2004; 92 (2): 568-77 (IF: 2,083)

Tanner B., Schiffer I.B., Heimerdinger C., Glawatz C., Schmidt M., Brulport M., Hermes M., Pasuello V., Boehm D.U., Neubert S., Naumann G., Kolbl H., Hengstler J.G. Perspectives for HER-2 blocking strategies in the mouse model: Rapid tumor remission depending on the tumor stage but no long-term heating. Geburtshilfe und Frauenheilkund; 64(8):821-830, 2004. (IF:0.502)
Boehm D.U., Hengstler J.G. Beerheide W., Kölbl H., Tanner B. Isolierung und Transplantation mesenchymaler Stannzellen aus Nabelschnurblut. Arch Gynecol Obstet 2004; 270: S10 (IF:0.666)
Dellas A., Puhl A., Schraml P., Thomke S.E. Ruschoff J., Mihatsch M.J., Moch H.
Molecular and clinicopathological analysis of ovarian carcinomas with and without microsatellite instability. Anticancer Res 2004; 24 (1): 361-9 (IF: 1.414)

Eger K., Hermes M., Uhlemann K., Rodewald S., Ortwein .J, Brulport M., Lupatsch F., Schiffer .IB., Heimerdinger C.K., Gebhard S., Bockamp E.O., Spangenberg C., Pravitt D., Trost T., Zabel B., Tanner B., Krugel U, Franke H., Illes P., Madaj-Sterba P., Beckers T., Hengstler J.G. 4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models. Biochem Biophys Res Commun 2004; 323 (3): 979-86 (IF=2.749)

Hawighorst-Knapstein S., Fusshoeller C., Franz C., Trautmann K., Schmidt M., Pilch H., Schoenefuss G., Knapstein P.G., Koelbl H., Kelleher D.K., Vaupel P. The impact of treatment for genital cancer on quality of life and body image--results of a prospective longitudinal 10-year study. Gynecol Oncol 2004; 94 (2): 398-403 (IF: 2,083)

Hefler L.A. Tempfer C.B., Grimm C., Lebrecht A., Ulbrich E., Heinze G., Leodolter S., Schneeberger C., Mueller M.W., Muendlein A., Koelbl H. Estrogen-metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women. Cancer 2004; 101 (2): 264-9 (IF: 2.864)

Lebrecht A., Grimm C., Lantzsch T., Ludwig E., Hefler L., Ulbrich E., Koelbl H. Monocyte chemoattractant protein-1 serum levels in patients with breast cancer.
Tumour Biol 2004; 25 (1-2): 14-7 (IF: 2.481)

Lebrecht A., Grimm C., Euller G., Ludwig E., Ulbrich E., Lantzsch T., Hefler L., Koelbl H. Transforming growth factor beta 1 serum levels in patients with preinvasive and invasive lesions of the breast. nt J Biol Markers 2004; 19 (3): 236-9 (IF: 1.578)

Taubert H., Blumke K., Bilkenroth U., Meye A., Kutz A, Bartel F., Lautenschlager C., Ulbrich E.J., Nass N., Holzhausen H.J., Koelbl H., Lebrecht A. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases. Gynecol Oncol 2004; 92 (1): 256-61 (IF: 2.614)

Viehweg P., Rotter K., Laniado M.Lampe D., Buchmann J., Kolbl H., Heywang-Kobrunner S. MR imaging of the contralateral breast in patients after breast-conserving therapy. Eur Radiol 2004; 14 (3): 402-8 (IF: 3.405)